Finance

Lists
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$5.27
-1.31%
(-0.070) 1D
ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TMCI...
Open
US$5.32
High
US$5.32
Low
US$4.95
Mkt. cap
345.50 ሚ
Avg. vol.
294.14 ሺ
Volume
287.80 ሺ
52-wk high
US$5.44
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
Open
US$5.32
High
US$5.32
Low
US$4.95
Mkt. cap
345.50 ሚ
Avg. vol.
294.14 ሺ
Volume
287.80 ሺ
52-wk high
US$5.44
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
News stories
From web sources and news partners
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc
CEO-
Employees450
Founded2014
Headquarters-
SectorHealth Care
IndustryMedical device
Websitetreace.com
Analyst ratings
Based on 1 analyst giving stock ratings to TMCI in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TMCI in the last 3 months
Highest
Current US$5.27
US$6.50 (+23.34%)
Average
US$6.50 (+23.34%)
Lowest
US$6.50 (+23.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Buy
Upgraded
US$6.50
+23.3%
11/09/2026
Ben Haynor
Lake Street
Buy
Reiterated
US$7.00
+32.8%
08/10/2026
Richard Newitter
Truist Financial
Hold
Reiterated
US$5.00
-5.1%
08/10/2026
Danielle Antalffy
UBS
Hold
Maintained
US$2.25
-57.3%
03/02/2026
Last report
6 ኖቬም 2026
Fiscal period
Q3 2026
-US$0.15 / -US$0.25
+39.80%beat
Revenue / Est. (USD)
48.25 ሚ / 47.71 ሚ
+1.14%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
62.52 ሚ
47.20 ሚ
45.38 ሚ
48.25 ሚ
Cost of goods sold
12.12 ሚ
9.79 ሚ
9.77 ሚ
9.90 ሚ
Cost of revenue
12.12 ሚ
9.79 ሚ
9.77 ሚ
9.90 ሚ
Research and development expenses
4.54 ሚ
4.62 ሚ
4.38 ሚ
4.49 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.78 ሚ
49.95 ሚ
46.19 ሚ
45.39 ሚ
Operating expense
56.32 ሚ
54.57 ሚ
50.56 ሚ
49.88 ሚ
Total operating expenses
68.44 ሚ
64.36 ሚ
60.33 ሚ
59.78 ሚ
Operating income
-5.92 ሚ
-17.17 ሚ
-14.96 ሚ
-11.53 ሚ
Other non operating income
88.00 ሺ
275.00 ሺ
202.00 ሺ
163.00 ሺ
EBT including unusual items
-9.39 ሚ
-17.96 ሚ
-15.87 ሚ
-12.57 ሚ
EBT excluding unusual items
-6.66 ሚ
-17.96 ሚ
-15.87 ሚ
-12.57 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.39 ሚ
-17.96 ሚ
-15.87 ሚ
-12.57 ሚ
Net profit margin
-15.03%
-38.05%
-34.98%
-26.04%
Earnings per share
-0.08
-0.12
-0.20
-0.15
Interest and investment income
527.00 ሺ
501.00 ሺ
445.00 ሺ
387.00 ሺ
Interest expense
-1.35 ሚ
-1.57 ሚ
-1.56 ሚ
-1.58 ሚ
Net interest expenses
-823.00 ሺ
-1.07 ሚ
-1.12 ሚ
-1.20 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.11 ሚ
-16.27 ሚ
-13.07 ሚ
-9.50 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች